These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 7912729

  • 1. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
    Ahmad A, Yao XA, Tanner JE, Cohen E, Menezes J.
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A, Ladha A, Cohen EA, Menezes J.
    Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
    [Abstract] [Full Text] [Related]

  • 4. Development of T-cell lines expressing functional HIV-1 envelope glycoproteins for evaluation of immune responses in HIV-infected individuals.
    Keler T, Li H, Cloyd MW, Vitale LA, Deo YM.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct 01; 13(2):117-26. PubMed ID: 8862276
    [Abstract] [Full Text] [Related]

  • 5. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
    Bird C, Gleeson PA, Ramsay A, Li P, McCluskey J.
    AIDS Res Hum Retroviruses; 1992 Dec 01; 8(12):1999-2009. PubMed ID: 1493050
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
    Jacotot E, Callebaut C, Blanco J, Rivière Y, Krust B, Hovanessian AG.
    Virology; 1996 Sep 15; 223(2):318-30. PubMed ID: 8806567
    [Abstract] [Full Text] [Related]

  • 8. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
    Guo HG, Veronese FM, Tschachler E, Pal R, Kalyanaraman VS, Gallo RC, Reitz MS.
    Virology; 1990 Jan 15; 174(1):217-24. PubMed ID: 2104682
    [Abstract] [Full Text] [Related]

  • 9. Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals.
    Ahmad A, Menezes J.
    AIDS; 1996 Feb 15; 10(2):143-9. PubMed ID: 8838701
    [Abstract] [Full Text] [Related]

  • 10. Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors.
    Paul NL, Marsh M, McKeating JA, Schulz TF, Liljeström P, Garoff H, Weiss RA.
    AIDS Res Hum Retroviruses; 1993 Oct 15; 9(10):963-70. PubMed ID: 8280479
    [Abstract] [Full Text] [Related]

  • 11. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y, Tian H, Lane HC, Cohen DI.
    J Immunol; 1993 Dec 15; 151(12):7337-48. PubMed ID: 7903106
    [Abstract] [Full Text] [Related]

  • 12. HIV-1 gp120/160 expressing cells upregulate HIV-1 LTR directed gene expression in a cell line transfected with HIV-1 LTR-reporter gene constructs.
    Merzouki A, Patel P, Cassol S, Ennaji M, Tailor P, Turcotte FR, O'Shaughnessy M, Arella M.
    Cell Mol Biol (Noisy-le-grand); 1995 May 15; 41(3):445-52. PubMed ID: 7580840
    [Abstract] [Full Text] [Related]

  • 13. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing.
    Koga Y, Nakamura K, Sasaki M, Kimura G, Nomoto K.
    Virology; 1994 May 15; 201(1):137-41. PubMed ID: 8178478
    [Abstract] [Full Text] [Related]

  • 14. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR, Strick N, Li YY, Jiang S.
    AIDS Res Hum Retroviruses; 1993 Dec 15; 9(12):1195-208. PubMed ID: 8142138
    [Abstract] [Full Text] [Related]

  • 15. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation.
    Berman PW, Nakamura GR.
    AIDS Res Hum Retroviruses; 1994 May 15; 10(5):585-93. PubMed ID: 7917519
    [Abstract] [Full Text] [Related]

  • 16. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A, Voss G, Hunsmann G.
    Virology; 1993 May 15; 194(1):37-43. PubMed ID: 8480426
    [Abstract] [Full Text] [Related]

  • 17. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.
    Callahan LN, Phelan M, Mallinson M, Norcross MA.
    J Virol; 1991 Mar 15; 65(3):1543-50. PubMed ID: 1995952
    [Abstract] [Full Text] [Related]

  • 18. A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope.
    Jonak ZL, Clark RK, Matour D, Trulli S, Craig R, Henri E, Lee EV, Greig R, Debouck C.
    AIDS Res Hum Retroviruses; 1993 Jan 15; 9(1):23-32. PubMed ID: 8094000
    [Abstract] [Full Text] [Related]

  • 19. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.
    Kant S, Zhang N, Barbé A, Routy JP, Tremblay C, Thomas R, Szabo J, Côté P, Trottier B, LeBlanc R, Rouleau D, Harris M, Dupuy FP, Bernard NF.
    Front Immunol; 2020 Jan 15; 11():583820. PubMed ID: 33101312
    [Abstract] [Full Text] [Related]

  • 20. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
    Fenouillet E, Jones I, Powell B, Schmitt D, Kieny MP, Gluckman JC.
    J Virol; 1993 Jan 15; 67(1):150-60. PubMed ID: 8093218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.